Age, gender, CCI score, tumor size, pretreatment CRP, SUVmax, history of other tumor, history of primary lung tumor, GOLD stage, the reason for referral to SBRT and pretreatment pulmonary fibrosis biomarker values (SP-D and KL-6) were analysed as clinical variables. This evidence concerns the gene MUC1 and neoplasm.